Recombinant vaccinia virus expressing prostate-specific antigen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant vaccinia virus expressing prostate-specific antigen, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate [Phase 1]